BIOG-BBioGaia AB (publ)
131.00SEK+0.08%Mkt Cap: 13.10B SEKP/E: 39.48Last update: 2026-05-13

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, a…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)39.48
P/E (Forward)29.91
PEG
P/B9.34
P/S8.48
EV/EBITDA25.86
EV/Revenue7.92
EPS (TTM)3.28
EPS (Forward)4.33
Cash Flow & Leverage
FCF Yield2.70%
FCF Margin22.91%
Operating CF306.57M SEK
CapEx (TTM)3.60M SEK
Net Debt/EBITDA-1.84
Net Debt-871.78M SEK
Technical
SMA 50118.53 (+10.5%)
SMA 200107.86 (+21.5%)
Beta
S&P 52W Chg24.23%
Avg Vol (30d)166.51K
Avg Vol (10d)238.59K
Technical Indicators
RSI (14)70.9
MACD3.3327
MACD Signal2.2353
MACD Hist.+1.0974
BB Upper132.16 SEK
BB Middle122.25 SEK
BB Lower112.35 SEK
BB Width16.21%
ATR (14)3.350 SEK
Vol Ratio (20d)0.51x
52W Range
93.2098% of range131.70
52W High131.70 SEK
52W Low93.20 SEK
Profitability
Gross Margin73.37%
EBITDA Margin30.62%
Profit Margin21.63%
Oper. Margin27.15%
ROE25.32%
ROA20.83%
Revenue Growth1.70%
Earnings Growth-1.30%
Balance Sheet
Debt/Equity
Current Ratio4.94
Quick Ratio3.27
Book Value/Sh13.87 SEK
Cash/Share8.618 SEK
Dividends
Fwd Div Rate1.640 SEK
Trail. Div Rate1.640 SEK
Div. Yield1.27%
5Y Avg Yield1.26%
Payout Ratio59.45%
Ex-Div DateMay 8, 2026
Pay Date
Splits
Last Split5:1
Split DateMay 18, 2022
Ownership
Shares Out.98.50M
Float84.12M
Insiders16.06%
Institutions60.38%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)165.00 SEK
Target Range165.00 SEK165.00 SEK
# Analysts1
Company
Market Cap13.10B SEK
Enterprise Value12.23B SEK
Revenue (TTM)1.54B SEK
Gross Profit1.13B SEK
Net Income (TTM)332.76M SEK
Revenue/Share15.27 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees242
Last Price131.00 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN